Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.

J, Feliu; P, Escudero; F, Llosa; M, Bolaños; JM, Vicent; A, Yubero; JJ, Sanz-Lacalle; R, Lopez; L, Lopez-Gómez; E, Casado; MJ, Gómez-Reina; M, González-Baron

doi:10.1200/jco.2005.06.035

Public

Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.

Shared by NobleBlocks on May 1, 2005 • 12:00 AM UTC

Authors:

Feliu J

Escudero P

Llosa F

Abstract

Purpose To determine the tolerability of capecitabine in elderly patients with advanced colorectal cancer (CRC).Patients and methods Fifty-one patients with advanced CRC who were >/= 70 years and considered ineligible for combination chemotherapy received oral capecitabine 1,250 mg/m(2) twice daily ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!